vx-745 has been researched along with Disease Exacerbation in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, J; Blackburn, K; Patrick, D | 1 |
1 trial(s) available for vx-745 and Disease Exacerbation
| Article | Year |
|---|---|
Neflamapimod: Clinical Phase 2b-Ready Oral Small Molecule Inhibitor of p38α to Reverse Synaptic Dysfunction in Early Alzheimer's Disease.
Topics: Alzheimer Disease; Disease Progression; Enzyme Inhibitors; Humans; Memory, Episodic; Mitogen-Activated Protein Kinase 14; Nootropic Agents; Pyridazines; Pyrimidines; Synapses | 2017 |